Purpose: The study aimed to measure the radiation-absorbed dose, effective dose, and associated risks of radiation-induced cancers during chest computed tomography (CT) imaging procedures at Square Hospital, Dhaka, Bangladesh. Methods: A total of 23 patients were examined using a 64-slice CT scanner and thermolumi nescence dosimeters. The dose-length product was recorded and converted into an equivalent effective dose using age-dependent conversion coefficients for multi-slice CT as provided by the European Guidelines. Organ doses were further converted into lifetime attributable risks (LARs) for cancer incidence and mortality based on data from the Biological Effects of Ionizing Radiation VII (BEIR VII) report. Results: The effective dose ranged from 3.1 millisieverts (mSv) to approximately 35.3 mSv. The mean LAR for cancer incidence was 20.6 cases per 100,000 males and 69.3 cases per 100,000 females. The LAR for cancer mortality was 21.5 cases per 100,000 males and 62.0 cases per 100,000 females. Female patients were found to face significantly higher risks than male patients. Conclusions The results highlight a noticeable increase in LAR for both cancer incidence and mortality due to chest CT examinations, particularly for female patients. These findings underscore the importance of carefully evaluating the risks associated with CT imaging procedures.

Purpose: The study aimed to measure the radiation-absorbed dose, effective dose, and associated risks of radiation-induced cancers during chest computed tomography (CT) imaging procedures at Square Hospital, Dhaka, Bangladesh. Methods: A total of 23 patients were examined using a 64-slice CT scanner and thermolumi nescence dosimeters. The dose-length product was recorded and converted into an equivalent effective dose using age-dependent conversion coefficients for multi-slice CT as provided by the European Guidelines. Organ doses were further converted into lifetime attributable risks (LARs) for cancer incidence and mortality based on data from the Biological Effects of Ionizing Radiation VII (BEIR VII) report. Results: The effective dose ranged from 3.1 millisieverts (mSv) to approximately 35.3 mSv. The mean LAR for cancer incidence was 20.6 cases per 100,000 males and 69.3 cases per 100,000 females. The LAR for cancer mortality was 21.5 cases per 100,000 males and 62.0 cases per 100,000 females. Female patients were found to face significantly higher risks than male patients. Conclusions The results highlight a noticeable increase in LAR for both cancer incidence and mortality due to chest CT examinations, particularly for female patients. These findings underscore the importance of carefully evaluating the risks associated with CT imaging procedures.

Purpose: The study aimed to measure the radiation-absorbed dose, effective dose, and associated risks of radiation-induced cancers during chest computed tomography (CT) imaging procedures at Square Hospital, Dhaka, Bangladesh. Methods: A total of 23 patients were examined using a 64-slice CT scanner and thermolumi nescence dosimeters. The dose-length product was recorded and converted into an equivalent effective dose using age-dependent conversion coefficients for multi-slice CT as provided by the European Guidelines. Organ doses were further converted into lifetime attributable risks (LARs) for cancer incidence and mortality based on data from the Biological Effects of Ionizing Radiation VII (BEIR VII) report. Results: The effective dose ranged from 3.1 millisieverts (mSv) to approximately 35.3 mSv. The mean LAR for cancer incidence was 20.6 cases per 100,000 males and 69.3 cases per 100,000 females. The LAR for cancer mortality was 21.5 cases per 100,000 males and 62.0 cases per 100,000 females. Female patients were found to face significantly higher risks than male patients. Conclusions The results highlight a noticeable increase in LAR for both cancer incidence and mortality due to chest CT examinations, particularly for female patients. These findings underscore the importance of carefully evaluating the risks associated with CT imaging procedures.

Purpose: The study aimed to measure the radiation-absorbed dose, effective dose, and associated risks of radiation-induced cancers during chest computed tomography (CT) imaging procedures at Square Hospital, Dhaka, Bangladesh. Methods: A total of 23 patients were examined using a 64-slice CT scanner and thermolumi nescence dosimeters. The dose-length product was recorded and converted into an equivalent effective dose using age-dependent conversion coefficients for multi-slice CT as provided by the European Guidelines. Organ doses were further converted into lifetime attributable risks (LARs) for cancer incidence and mortality based on data from the Biological Effects of Ionizing Radiation VII (BEIR VII) report. Results: The effective dose ranged from 3.1 millisieverts (mSv) to approximately 35.3 mSv. The mean LAR for cancer incidence was 20.6 cases per 100,000 males and 69.3 cases per 100,000 females. The LAR for cancer mortality was 21.5 cases per 100,000 males and 62.0 cases per 100,000 females. Female patients were found to face significantly higher risks than male patients. Conclusions The results highlight a noticeable increase in LAR for both cancer incidence and mortality due to chest CT examinations, particularly for female patients. These findings underscore the importance of carefully evaluating the risks associated with CT imaging procedures.

Purpose: The study aimed to measure the radiation-absorbed dose, effective dose, and associated risks of radiation-induced cancers during chest computed tomography (CT) imaging procedures at Square Hospital, Dhaka, Bangladesh. Methods: A total of 23 patients were examined using a 64-slice CT scanner and thermolumi nescence dosimeters. The dose-length product was recorded and converted into an equivalent effective dose using age-dependent conversion coefficients for multi-slice CT as provided by the European Guidelines. Organ doses were further converted into lifetime attributable risks (LARs) for cancer incidence and mortality based on data from the Biological Effects of Ionizing Radiation VII (BEIR VII) report. Results: The effective dose ranged from 3.1 millisieverts (mSv) to approximately 35.3 mSv. The mean LAR for cancer incidence was 20.6 cases per 100,000 males and 69.3 cases per 100,000 females. The LAR for cancer mortality was 21.5 cases per 100,000 males and 62.0 cases per 100,000 females. Female patients were found to face significantly higher risks than male patients. Conclusions The results highlight a noticeable increase in LAR for both cancer incidence and mortality due to chest CT examinations, particularly for female patients. These findings underscore the importance of carefully evaluating the risks associated with CT imaging procedures.

OBJECTIVES: This is the first study that estimates the incidence and mortality rate for colorectal cancer (CRC) patients in Malaysia by sex and ethnicity. METHODS: The 4,501 patients were selected from National Cancer Patient Registry-Colorectal Cancer data. Patient survival status was cross-checked with the National Registration Department. The age-standardised rate (ASR) was calculated as the proportion of CRC cases (incidence) and deaths (mortality) from 2008 to 2013, weighted by the age structure of the population, as determined by the Department of Statistics Malaysia and the World Health Organization world standard population distribution. RESULTS: The overall incidence rate for CRC was 21.32 cases per 100,000. Those of Chinese ethnicity had the highest CRC incidence (27.35), followed by the Malay (18.95), and Indian (17.55) ethnicities. The ASR incidence rate of CRC was 1.33 times higher among males than females (24.16 and 18.14 per 100,000, respectively). The 2011 (44.7%) CRC deaths were recorded. The overall ASR of mortality was 9.79 cases, with 11.85 among the Chinese, followed by 9.56 among the Malays and 7.08 among the Indians. The ASR of mortality was 1.42 times higher among males (11.46) than females (8.05). CONCLUSIONS: CRC incidence and mortality is higher in males than females. Individuals of Chinese ethnicity have the highest incidence of CRC, followed by the Malay and Indian ethnicities. The same trends were observed for the age-standardised mortality rate.
Asian Continental Ancestry Group ; Colorectal Neoplasms* ; Demography ; Ethnic Groups ; Female ; Humans ; Incidence* ; Malaysia* ; Male ; Mortality* ; World Health Organization